Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Biobanking market.
Trusted Business Insights presents an updated and Latest Study on Biobanking Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Biobanking market during the forecast period (2019-2029).It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.
Get Sample Copy of this Report @ Biobanking Market Size, Share & Industry Analysis, By Sample Storage (Blood, Cells & Tissue, and Others), By Application (Regenerative Medicines, Life Sciences, and Others), By Settings (Academic Medical Institutes, and Pharmaceutical & Biotechnology Companies), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)
The global biobanking market size was USD 25.09 billion in 2018 and is projected to reach USD 49.46 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period.
We have updated Biobanking Market with respect to COVID-19 Impact.Inquire before buying
A biobank is a practice of creating wide-range repositories for the collection, storage, and distribution of human samples such as blood, plasma, serum, urine, tissues, cells, and others. The field of biobanking has tremendously evolved over the years and is currently witnessing a significant growth. The integration of advanced technologies, data analytics, and automation has changed the traditional biobanks into virtual biobanks, giving rise to a transformative market potential. Globally, there are several types of biobanks such as, disease-oriented biobanks, population-based biobanks, tissue banks, and blood banks which are contributing to the market growth. Growing investments for drug development and increasing prevalence of disastrous diseases such as cancer, respiratory diseases, Alzheimers disease, and others are prominently leveraging the growth of this market.
MARKET TRENDS
Sustainable Biobanking is Likely to Propel Market GrowthSustainability of a biobank is crucial to remain operative and effective in the market. Despite financial support from public organizations, insecurity for long-term funding is a significant concern today. To achieve greater sustainability, a balance between financial, operational, and social dimensions of the biobank is necessary. Increased sustainability of the biobank would lead to the generation of higher revenue and thus, propel the global biobanking market. Currently, biobanks, as well as several industry stakeholders, are approaching various strategies to meet the sustainability goal. For instance, Biobanking and Bimolecular Resources Research Infrastructure (BBMRI) based in the Netherlands, has made a series on sustainable biobanking, which includes nine recommendations (for example, draft a business plan, user-centered perspective, choosing of business model, and others) for biobanks to achieve sustainability. The set also provides business tools for biobanks and case study analysis. Such strategies are the helping hand for biobanks across the globe to achieve faster sustainability during the forecast period.
MARKET DRIVERS
Facility to Conserve Cord Blood Stem Cells to Proliferate Market Potential
Cord blood is the blood that remains in the umbilical cord post-delivery of a baby. It is the most abundant source of stem cells that is conserved and processed for medical research. The conservation of cord blood is on high demand in the field of biobanking and thus, is likely to increase the potential of the market in the coming years. Moreover, the launch of cord blood stem cell biobanking is majorly driving the market. For instance, in February 2020, Lund University in Sweden launched the worlds largest stem cell biobanking. The biobank will help researchers understand the origin of the most common disorders, such as Alzheimers disease and Parkinsons disease. Additionally, increasing prevalence of chronic diseases worldwide also plays a significant role in contributing to the launch of stem cell biobanks. Therefore, a rising number of biobanks will drive the biobanking market growth in the forecast period.
Launch of Software for Virtual Biobanking to Fuel Market Growth
In recent years, this market has rapidly undergone an evolution. The integration of advanced technologies with the biobanking system is currently the foremost market driver. Virtual biobanking is now revolutionizing the biobanking system as it minimizes time constraints and allows researchers to conduct the research smoothly. Virtual biobanking has helped the biobanks to generate higher revenue, thus increasing the market value and propelling the market growth. In addition, multiple software companies are into the development of software for the ease of the biobanking system and the adoption of a virtual biobanking system. For example, in September 2018, Technidata Medical Software launched a feature for its TDBioBank software solution. This software solution helps the biobank to gain visibility and improve the quality of the service provided to the customers. Thus, virtual biobanking is set to have multiple advantages and aid in the generation of higher revenue.
MARKET RESTRAINT
Ethical Challenges in Emerging Countries to Limit Growth
Ethical implication is an integral part of biobanking with respect to informed consent from patients, handling, storage, and distribution of samples. But, factors such as high level of poverty, lower literacy rates, and traditional practices in the emerging countries cause hindrance in the implications. Additionally, the lack of training and counselling on medical ethics to the respective personnel of biobank is another factor to limit the growth of the global biobanking market. Moreover, the misconceptions of biobanking in the patient population can also affect the growth of the market. The above-mentioned factors are likely to affect the overall value of the market in the coming years.
SEGMENTATION
By Sample Storage Analysis
The Blood Segment to Dominate Stoked by Increasing Need for SamplesBased on sample storage, the market is segmented into blood, cells & tissue, and others. The blood segment dominated the global market in terms of market value and market share in 2018. Collection, storage, and distribution of blood samples have emerged mainly in the nations across the globe owing to a rise in the number of infectious diseases and demand for curative measures. Blood samples are considered as a crucial biospecimen as they contain DNA and RNA which are used in conductance of research activities. Thus, blood samples are primarily requested at the biobank by the pharmaceutical industries as well as academic medical institutions. According to the trans-hit bio database, 85% of blood samples are needed by the industry for non-cancerous studies as compared to other sample types.
Further, cells & tissues are anticipated to emerge as the fastest-growing segment in the global market. The faster growth is in accordance with the increasing demand for cells and tissue samples for investigating complex disorders such as Alzheimers disease, cancer, and others. Other samples, such as urine, hair, and many more, are anticipated to mark a slower growth during the forecast period owing to lesser demand and distribution of the sample.
By Application Analysis
Life Science Segment to Lead Backed by Rising Demand for Samples from Academic InstitutionsIn terms of application, the market is segmented into regenerative medicines, life science, and others. The life science segment dominated the global biobanking market in 2018. The dominance is attributed to the growth in the supply of sample distribution to the academic institutions and pharmaceutical R&D for clinical applications. Increasing prevalence of complex diseases and the need for curative measures are imposing pressure on the scientists. Additionally, the regenerative medicine segment is anticipated to grow at a higher CAGR during the forecast period. Furthermore, research and pharmaceutical companies globally have collaborated to conduct clinical trials of regenerative medicines for various applications.
Multiple clinical studies are in the pipeline, thus increasing demand for samples from biobanks. For example, in September 2019, the USFDA granted regenerative medicine advanced therapy designation for SB623 cell therapy of SanBio Group. Cell therapy is in the phase-2 clinical study indicated for the treatment of traumatic brain injury. The surging demand for personalized medicine is expected to play a critical role in human health. Hence, the demand for high-quality samples from biobanks is likely to mark a potential growth for the regenerative segment in the coming years.
By Settings Analysis
Establishment of Biobanks at Academic Medical Institutions to Aid Higher Market ValueBy settings, the global biobanking market is classified into academic medical institutions and pharmaceutical & biotechnology companies. In 2018, the academic medical institutions segment held the leading position in the market. The dominance is attributed to factors such as higher investments in R&D and a growing need for multiple samples to carry research activities. Increasing prevalence of cancer, Alzheimers disease, and others is demanding for higher curative measures, thus promoting research activities. Hence, the establishment of biobanks by the medical institutions has aided in the generation of higher market value. Biobanks at pharmaceutical and biotechnology companies also have a considerable share in the market owing to the adoption of advanced technologies and establishment of biobanks.
REGIONAL ANALYSIS
Europe dominated the market with market size of USD 8.93 billion in 2018. This dominance is attributed to the presence of well-established biobanks in the Nordic countries such as Sweden, Norway, Denmark, and others. According to an article posted in Global Engage, a producer of conferences and summits for the Life Science and pharmaceutical sector, approximately 40% of the population in Iceland have contributed DNA, which is safely and privately stored in the biobanks. Such contributions and growing supply of samples are adding to the market size of the European biobank market. Moreover, continuous efforts in R&D by European pharmaceuticals are also one of the factors responsible for the higher market share of the region. North America holds the second position in this market owing to the conductance of multiple clinical trials by the research institutes and pharmaceutical companies. Also, increasing technological advancements to set-up virtual biobank is a factor responsible for the geographical position of North America. Asia Pacific is expected to register a higher CAGR during the forecast period owing to higher sales of blood and cell samples to the academic medical institutions for research purposes. Additionally, growing investments in setting up well-structured biobanks are also responsible for surging the biobank market in the Asia Pacific region during the forecast period.On the other hand, Latin America and the Middle East & Africa are likely to exhibit a considerably lower growth in terms of market value owing to ethical challenges and smaller investments in the maintenance of biobank.
KEY INDUSTRY PLAYERS
Biobank Graz and Shanghai Zhangjiang Biobank Have Storage Targets of Million SamplesThe global biobanking market is consolidated with a number of banks worldwide. Some banks are disease-oriented, while some are population-based biobanks. Other banks, such as tissue banks, cell-specific biobank, blood biobank, and many others, are also contributing to the market. Biobank Graz is a publicly funded biobank having about 20 million sample collection facilities. Working on automation technology, Biobank Graz distributes samples ethically and scientifically to academic institutions worldwide. It is also known as a central hub for biomedical research. Similarly, biobanks having substantial storage facilities and distribution strategies are anticipated to contribute to the enhancement and market value of the global market.
LIST OF KEY COMPAINES PROFILED:
KEY INDUSTRY DEVELOPMENTS:
September 2019 The U.K launched a USD 247 million DNA database for Genome Decoding Research Project. U.K. Biobank, as a part of the project, will analyze and sequence the genetic codes of 500,000 volunteers. Pharma giants such as GlaxoSmithKline plc and Johnson and Johnson are also a part of the project.
REPORT COVERAGE
The biobanking market report provides a detailed analysis of the market and focuses on key aspects such as leading biobanks, sample types, and leading applications of the sample. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years. It further highlights some of the growth-stimulating factors and restraints, helping the reader to gain in-depth knowledge about the market.
Report Scope & Segmentation
Segmentation
By Sample Storage
By Application
By Settings
By Geography
Looking for more? Check out our repository for all available reports on Biobanking in related sectors.
Quick Read Table of Contents of this Report @ Biobanking Market Size, Share & Industry Analysis, By Sample Storage (Blood, Cells & Tissue, and Others), By Application (Regenerative Medicines, Life Sciences, and Others), By Settings (Academic Medical Institutes, and Pharmaceutical & Biotechnology Companies), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)
Trusted Business InsightsShelly ArnoldMedia & Marketing ExecutiveEmail Me For Any ClarificationsConnect on LinkedInClick to follow Trusted Business Insights LinkedIn for Market Data and Updates.US: +1 646 568 9797UK: +44 330 808 0580
Continued here:
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
- Repeated concussions can alter heart activity and impact the heart ... - Philippine Canadian Inquirer - November 29th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - PharmiWeb.com - November 27th, 2023
- Vita 34 increases revenue and earnings in Q3 2023 and further ... - Marketscreener.com - November 25th, 2023
- FY 2021 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- New study aims to expand access to stem cell transplant using ... - Healio - November 23rd, 2023
- Impact of GVHD Prophylaxis on CMV Reactivation and Disease ... - Cancer Network - November 23rd, 2023
- The Top 25 Women Leaders in Biotechnology of 2023 - The Healthcare Technology Report. - November 21st, 2023
- First Edition: November 20, 2023 - KFF Health News - November 21st, 2023
- An essential guide to the building blocks of life - Gates Notes - November 21st, 2023
- A Simple Way to Save Premature Babies - The New York Times - November 19th, 2023
- Perspectives of current understanding and therapeutics of Diamond ... - Nature.com - November 17th, 2023
- Brain Organoids: Should They Be Considered People? - BBVA OpenMind - November 17th, 2023
- Understanding the cause of childhood Alzheimer's - ASBMB Today - November 17th, 2023
- Peripheral nerve regeneration through nanofiber scaffolds | IJN - Dove Medical Press - November 15th, 2023
- Are STEM CELL EXOSOMES the secret to a 'snatched' jawline? Discover the products that influencers are claiming - Daily Mail - November 13th, 2023
- CAR-NK: The next generation in hematological malignancy treatment - News-Medical.Net - November 13th, 2023
- Regenerative Medicine | Top Regenerative Medicine Solution ... - Healthcare Tech Outlook - November 13th, 2023
- Stem cell therapy, emerging solution to slow down ageing - Punch Newspapers - November 13th, 2023
- Improving Cord Blood Transplantation Outcomes for Adults With ... - On Cancer - Memorial Sloan Kettering - November 11th, 2023
- 8 Ways To Save Lives With Canadian Blood Services & You Can ... - Narcity Canada - November 11th, 2023
- Internal investigation by Vita 34 AG reveals irregularities related to a ... - Marketscreener.com - November 11th, 2023
- 'We worried the worst would happen' - Yorkshire Children's Trust ... - The Yorkshire Post - November 11th, 2023
- Minor GPI(-) granulocyte populations in aplastic anemia and healthy ... - Nature.com - November 9th, 2023
- Repeated treatment with ProTrans is immunologically safe ... - Marketscreener.com - November 7th, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells - Benzinga - November 7th, 2023
- Health Canada issues warning on cord blood stored in Edmonton - CBC News - November 3rd, 2023
- Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting - Yahoo... - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance ... - InvestorsObserver - November 3rd, 2023
- Go with the flow and achieve hearing restoration - Drug Discovery News - November 3rd, 2023
- Cell Therapy Market to Witness Exponential Growth by 2031 ... - Argyle Report - November 1st, 2023
- Cross-talk between Myeloid and B Cells Shapes the Distinct ... - Cancer Discovery - November 1st, 2023
- Comparison of effects of HucMSCs, exosomes, and conditioned ... - Nature.com - October 28th, 2023
- The structural and functional complexity of the integrative ... - Science - October 28th, 2023
- Global Primary Cells Market to Witness Growth at 11.41% CAGR to ... - GlobeNewswire - October 26th, 2023
- Hma-Qubec celebrates 25 years of giving life in anniversary ad - - The Message - October 26th, 2023
- Improvement of thermal-stability of chondroitinase ABCI immobilized ... - Nature.com - October 26th, 2023
- Sydney Couple Overcomes Sperm Antibody Issue to Welcome Baby - OPP.Today - October 24th, 2023
- New Research Reveals Surprising Issue with Sperm and Fertility - CityLife - October 24th, 2023
- Biobanking Market to Observe Prominent CAGR of 6.10% by 2029 ... - PharmiWeb.com - October 21st, 2023
- TV shows like BBC's Call The Midwife and C4's One Born Every Minute 'are inaccurately depicting childbirth' an - Daily Mail - October 19th, 2023
- Advances in medical and technological research and SCI - Clyde & Co - October 18th, 2023
- Prognostic Value of Hematogones in Patients With Hematopoietic ... - Cureus - October 18th, 2023
- Stem-Cell Therapy: Filling Gaps in Oro-Maxillofacial Region - Cureus - October 18th, 2023
- The neonatal southern white rhinoceros ovary contains oogonia in ... - Nature.com - October 18th, 2023
- OMG: Sperm injury led to rare baby struggle - news.com.au - October 18th, 2023
- Experts Explain how MS Impacts the Eyes and Eye Health - Health Central - October 18th, 2023
- Newly identified stem cells can lure breast cancer to the spine - Science News Magazine - October 15th, 2023
- Cases of HIV cure | aidsmap - aidsmap - October 15th, 2023
- HokUS-10 scoring system predicts the treatment outcome for ... - Nature.com - October 13th, 2023
Recent Comments